| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGACAGCAGCGACUUUAGGCUGGAUAAUAGUCAAAUUCUUACCUCGCUC… | 1092 nt | 0.3755 | |
| AGACAGCAGCGACUUUAGGCUGGAUAAUAGUCAAAUUCUUACCUCGCUC… | 1123 nt | 0.3802 | |
| AGACAGCAGCGACUUUAGGCUGGAUAAUAGUCAAAUUCUUACCUCGCUC… | 4012 nt | 0.3537 | |
| AGACAGCAGCGACUUUAGGCUGGAUAAUAGUCAAAUUCUUACCUCGCUC… | 3890 nt | 0.3483 | |
| AGACAGCAGCGACUUUAGGCUGGAUAAUAGUCAAAUUCUUACCUCGCUC… | 3981 nt | 0.3522 | |
| AGACAGCAGCGACUUUAGGCUGGAUAAUAGUCAAAUUCUUACCUCGCUC… | 3859 nt | 0.3467 |
This gene encodes a Kunitz-type serine protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. Inhibition of the encoded protein restores hemostasis in animal models of hemophilia. This gene encodes multiple protein isoforms that differ in their inhibitory activity, specificity and cellular localization. [provided by RefSeq, Jul 2016]
A study in pediatric septic shock patients identified two subclasses based on whole blood RNA expression profiles, where Subclass 1 was characterized by upregulated innate immunity and worse clinical outcomes [Yang et al. DOI:10.1186/s13054-023-04689-y].